3 Must-Haves to Deploy Remote Clinical Trials

Decentralized clinical trials (DCTs) are becoming one of the most dynamic ways to grow clinical research organizations.  The ability to easily and effectively deploy remote trials elevates opportunities for research sites, priming them for increased sponsor awards and patient engagement. In order to capitalize all the benefits DCTs have to offer, clinical research sites must embrace the myriad of technologies that make remote trials possible. Here are three must-have decentralized trial tools:

  1. Video. Remote trials help remove the most common hurdle for patients – location. However, less in-person meetings opens the door for less-than-optimal patient engagement. In order to maximize the remote patient experience, decentralized trials require technology that assists with virtual visits, notably patient-centric meeting video tools. Secure video conferencing is a critical component for remote trial model success as it allows sites to complete study visits virtually, increases site revenue, and reduces costs of in-person monitoring. The best video solutions don’t require special app downloads or installation, making it easy for patients and clinicians to gain access. They should also allow multiple participants in case patients have home health care or family members that are involved in their trial participation. Further, integrating video with CTMS eliminates multi-system visit data entry. See remote trial video at work. 
  1. Electronic Consent Application. Maintaining updated hard copy consent documents are complicated for site-centric clinical research models, but they are completely impractical for remote trial work. eConsent systems digitize the process of obtaining initial and ongoing informed consent, a necessity for all trials, but especially critical when patients never physically enter a site. Direct entry increases the accuracy and completeness of information, helping increase sponsor satisfaction and ensure audit preparedness. eConsent can also help engage geographically dispersed participants by using color, images, audio, video and other elements to elevate the experience from static to dynamic. Digitizing the process of obtaining consent can increase the chances of a positive experience and boost patient retention. Compare the benefits of paper vs. eConsent and use this checklist to evaluate potential eConsent partners
  1. Remote Workflow Capability. A chief concern regarding remote trial work is preserving source document workflows, critical approval processes, and CRF completion. Remote workflows are also something increasingly sought out by sponsors who are less inclined to consider sites without an effective solution. Even if a site has transitioned to mostly remote workflows, leveraging tools like CC CTMS and CCeReg, the process of transitioning to remote data capture and CRF completion can still be a challenge. In order to keep the process moving and provide timely access to remote PI’s and monitors to avoid unnecessary delays, sites need an effective eSource system. eSource serves to not only capture screening and visit data effectively, but also empowers team members, reviewers and approvers working remotely to leverage 21 CFR part 11 compliant eCRF workflows instantaneously. See how eSource increases remote workflow capabilities.  

Learn more about how these tools and other considerations can help your site Create New Opportunities with Decentralized Trials in our latest resource guide. 

See CCTrialSuite In Action

CCTrialSuite has the only Clinical Trial Management System (CTMS) that cuts out the complexity in clinical trial software with tools designed to work for clinical trials.